Acadia Healthcare Company (ACHC) Cash from Financing Activities (2010 - 2026)

Acadia Healthcare Company (ACHC) has reported Cash from Financing Activities for 17 consecutive years, with -$116.6 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash from Financing Activities fell 302.86% year-over-year to -$116.6 million; the TTM figure through Jun 2026 stood at $144.4 million (down 59.86% YoY), while the FY2025 annual figure was $481.3 million, down 17.45% from the prior year.
• Cash from Financing Activities retreated to -$116.6 million in Q2 2026 per ACHC's latest filing, from $23.9 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $483.1 million in Q1 2024 and bottomed at -$116.6 million in Q2 2026.
• Historically, Cash from Financing Activities has averaged $44.3 million across 5 years, with a median of -$1.8 million in 2022.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 1133.2% — and 2024, when it surged 4368.68%.
• Acadia Healthcare Company's Cash from Financing Activities stood at -$17.3 million in 2022, then jumped by 67.31% to -$5.7 million in 2023, then jumped by 1528.88% to $80.8 million in 2024, then jumped by 139.24% to $193.3 million in 2025, then slumped by 160.31% to -$116.6 million in 2026.
• Business Quant data shows ACHC's Cash from Financing Activities at -$116.6 million in Q2 2026, $23.9 million in Q1 2026, and $193.3 million in Q4 2025.